87
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD

, , , , , , & show all
Pages 1469-1476 | Published online: 30 Jun 2016

References

  • Global Initiative for Chronic Obstructive Lung Disease (GOLD) [homepage on the Internet]Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease [updated 2015] Available from: http://www.goldcopd.orgAccessed September 9, 2015
  • National Institute for Clinical ExcellenceChronic Obstructive Pulmonary Disease Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care Clinical Guideline 12LondonNational Institute for Clinical Excellence2004
  • American Thoracic SocietyStandards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthmaAm Rev Respir Dis19871362252443605835
  • COMBIVENT Inhalation Aerosol Study GroupIn chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trialChest1994105141114198181328
  • CPMP/391/97Consolidation of CPMP Reviews of Alternatives to Chlorofluorocarbon PropellantsLondon1997
  • NielsenKGSkovMKlugBIfversenMBisgaardHFlow-dependent effect of formoterol dry-powder inhaled from the Aerolizer®Eur Respir J199710210521099311511
  • SmithKJChanH-KBrownKFInfluence of flow rate on aerosol particle size distributions from pressurized and breath-actuated inhalersJ Aerosol Med19981123124510346666
  • BorgstromLBondessonEMorenFTrofastENewmanSPLung deposition of budesonide inhaled via turbuhaler: a comparison with terbutaline sulphate in normal subjectsEur Respir J1994769738143834
  • HartungTKAllbuttHDewarMInnesJACromptonGKMoving from CFC aerosol to HFA aerosol or dry powder inhalers: what do patients think?Respiration20026931431912169743
  • ZuWallackRDe SalvoMCKaelinTCombivent Respimat Inhaler Study GroupEfficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDIRespir Med20101041179118820172704
  • BhomeACOPD in India: iceberg or volcano?J Thorac Dis20124329830922754670
  • JainNKThakkarMSJainNRohanKASharmaMChronic obstructive pulmonary disease: does gender really matter?Lung India201128425826222084538
  • Lopez VarelaMVMontes de OcaMSex-related differences in COPD in five Latin American cities: the PLATINO studyEur Respir J2010361034104120378599
  • ChabraSKRajpalSGuptaSPattern of smoking in Delhi and comparison of chronic respiratory morbidity among beedi and cigarette smokersIndian J Chest Dis Allied Sci200143192611370502
  • JamesGDonaldsonGWedzichaJANazarethITrends in management and outcome of COPD patients in primary care, 2000–2009, a retrospective cohort studyNPJ Prim Care Respir Med2014241401524990313
  • SinghDFergusonGTBolitschekJTiotropium and olodaterol shows clinically meaningful improvements in quality of lifeRespir Med2015109101312131926320402
  • CharlesMSBlanchetteCMSilverHLavalleeDDalalAAMapelDAdherence to controller therapy for chronic obstructive pulmonary disease: a reviewCurr Med Res Opin2010262421242920815661
  • RestrepoRAlvarezMWittnebelLMedication adherence issues in patients treated for COPDInt J Chron Obstruct Pulmon Dis2008337138418990964